Xiaolu Zhu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Outcomes of patients with hematological malignancies complicated with autoimmune diseases after allogeneic hematopoietic stem cell transplantation: A ten-year real-world study.
Journal: Journal of translational internal medicine
Published: August 27, 2026
All-Trans Retinoic Acid plus Eltrombopag for Refractory/Relapsed Immune Thrombocytopenia.
Journal: NEJM evidence
Published: July 28, 2026
Unmasking the link: pulmonary embolism risk and outcomes in adults with immune thrombocytopenia.
Journal: Journal of thrombosis and haemostasis : JTH
Published: December 15, 2025
Risk Factors and Outcomes of Pneumocystis jirovecii Pneumonia after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancy: A 10-Yr Cohort Study.
Journal: Transplantation and cellular therapy
Published: December 12, 2025
Clinical profiling and outcomes of ischaemic stroke patients with immune thrombocytopenia: A multicentre retrospective study.
Journal: British journal of haematology
Published: November 20, 2025
Outcomes and risk factors of second allogeneic haematopoietic stem cell transplantation in patients with relapsed haematological malignancy after first transplantation.
Journal: British journal of haematology
Published: July 29, 2025
Thrombotic thrombocytopenic purpura following allogeneic hematopoietic stem cell transplantation: a rare but fatal complication.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 23, 2025
Donor macrophage pyroptosis contributes to the development of aGVHD.
Journal: Science China. Life sciences
Published: December 31, 2024
Clinical features and prognostic nomogram for therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
Journal: Cancer letters
Published: December 13, 2024
Sintilimab plus decitabine for higher-risk treatment-naïve myelodysplastic syndromes: efficacy, safety, and biomarker analysis of a phase II, single-arm trial.
Journal: Journal for immunotherapy of cancer
Published: October 29, 2024
Progesterone regulates gut microbiota mediating bone marrow mesenchymal stem cell injury in immune thrombocytopenia patients during pregnancy.
Journal: Journal of thrombosis and haemostasis : JTH
Published: August 25, 2024
Only FLT3-ITD co-mutation did not have a deleterious effect on acute myeloid leukemia patients with NPM1 mutation, but concomitant with DNMT3A co-mutation or a < 3log reduction of MRD2 predicted poor survival.
Journal: Annals of hematology
Published: June 10, 2024
Last Updated: 09/26/2026